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OBJECTIVES We sought to document whether a physiologic change in gender has any effect on coronary
arterial size.
BACKGROUND The coronary arteries are smaller in women, even after correction for body surface area (BSA).
These differences may contribute to adverse clinical outcomes after coronary artery bypass
graft surgery and myocardial infarction in women. In male and female transsexuals,
pharmacologic doses of estrogens and androgens significantly influence vascular diameter.
Thus, gender differences in the coronary vasculature may be a reflection of the hormonal
environment.
METHODS In 86 patients who had undergone orthotopic heart transplantation, serial intravascular
ultrasound studies of the proximal left anterior descending coronary artery (LAD) were
analyzed. Changes in vessel area (VA) over the first or second post-transplant year were
recorded, and comparisons were made between donor hearts that were transplanted in a
patient of the same gender and those that were transplanted in a patient of the opposite
gender.
RESULTS Vessel area of the proximal LAD increased over time in all patient groups. In hearts
transplanted within the same gender and in male donor hearts transplanted to female
recipients, the change was small and not significant. However, in hearts transplanted from
female donors to male recipients, there was a substantial and highly significant increase in
LAD VA (median 16.13 to 17.88 mm2; p  0.01). This increase was not explained by
confounding due to changes in BSA or left ventricular wall thickness.
CONCLUSIONS This pattern of arterial remodeling early after heart transplantation supports a link between
host gender and coronary arterial size. (J Am Coll Cardiol 2003;41:1539–46) © 2003 by
the American College of Cardiology Foundation
Observational evidence suggests that coronary artery disease
(CAD) in women is different from that seen in men (1).
The relative importance of risk factors is different, the
disease presents later in women, and an atypical presenta-
tion is more frequent. The first disease manifestation is
more likely to be angina pectoris in women, whereas it is
acute myocardial infarction (MI) in men (2). Furthermore,
morbidity and early mortality rates after MI (3) and after
coronary artery bypass graft surgery (CABG) are substan-
tially higher in women (4).
The reasons underlying these adverse clinical outcomes
are likely to be multifactorial. Confounding factors may be
partly responsible: female patients tend to be older and have
a more complicated clinical presentation (5), and compared
with men, they are marginally less likely to receive reperfu-
sion therapy for acute MI (6). Anatomic differences in
coronary size may also be important. In patients undergoing
CABG, the mean luminal diameters of the left coronary
arteries were significantly smaller in women (4), and smaller
arterial size was an independent predictor of postoperative
mortality, irrespective of gender (4). Intravascular ultra-
sound (IVUS) has also shown that the left main coronary
artery (LMCA) and left anterior descending coronary artery
(LAD) are significantly larger in men, even after correction
for body surface area (BSA) (7).
Gender differences in coronary dimensions that persist
after correction for BSA may be due to the influences of sex
hormones on coronary arterial structure or tone. The vas-
cular effects of exogenous sex hormone administration have
been explored in small cross-sectional studies in men receiv-
ing high-dose estrogens (8) and in women receiving high-
dose androgens (9). Compared with their respective same-
sex controls, brachial artery diameter was significantly
smaller in men taking pharmacologic doses of estrogens (8)
and significantly larger in women taking high-dose andro-
gens (9).
The present study aimed to further evaluate the relation-
ship between gender and coronary arterial size. We analyzed
the changes in the vessel area (VA) of the proximal LAD, as
measured by IVUS, that occurred after hearts were trans-
planted from a donor to a recipient of the opposite gender,
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compared with those that were transplanted within the
same gender. The hypothesis was that hearts transplanted
across gender would exhibit changes in coronary arterial size
that would differ from those seen in hearts transplanted
within the same gender.
METHODS
Patients who had undergone serial IVUS studies spanning
either the first (i.e., within 4 weeks after heart transplanta-
tion and at the first annual evaluation) or second (i.e., at the
first and second annual evaluations) post-transplant year
were eligible for this study. Most were drawn from the
IVUS database of the Multicenter Intravascular Ultrasound
Transplant Study (10), in which 299 patients at eight heart
transplant centers underwent serial annual IVUS examina-
tions after heart transplantation. Additional patients were
drawn from the Stanford University database of IVUS
recordings from heart transplant patients who were not part
of that study.
Intravascular ultrasound recordings that included ade-
quate images of the proximal segment of the LAD (proxi-
mal to the first diagonal branch) were identified. Only
disease-free vessels were included to avoid the potential
confounding effects of vascular remodeling in response to
atherosclerosis. All female heart transplant recipients were
included, as long as they met the aforementioned criteria. In
addition, all male recipients of a female donor heart were
included, as were selected male recipients of a male donor
heart (the largest patient group). Selection of patients for
the male-to-male group followed the identification of the
other three patient groups and was performed by choosing
patients of similar donor age, similar recipient age, and
similar dates of IVUS studies to all other patient groups.
Furthermore, we ensured that the distribution of serial
IVUS studies between the first and second post-transplant
year was approximately equal in this group, as in the other
patient groups.
Intravascular ultrasound imaging and analysis. The im-
aging protocol has been described (10). In brief, after
coronary angiography and myocardial biopsy, intravenous
heparin (5,000 to 10,000 U), sublingual nitroglycerin, and
intracoronary nitroglycerin (200 g) were administered. An
angioplasty guide wire (0.014 in.) was advanced to the distal
LAD, over which a 4.3F, 30-MHz IVUS catheter (Cardio-
vascular Imaging Systems, Sunnyvale, California) was ad-
vanced to the distal segment. Ultrasound time-gain com-
pensation settings were adjusted to allow maximal gray-scale
differentiation for the cross-sectional images within the
target segment. In addition to selection of specific sites for
follow-up comparisons, a continuous manual pullback re-
cording of the artery was made until the guiding catheter
artifact appeared. Images were recorded on S-VHS video-
tape and analyzed off-line. To minimize interobserver vari-
ability, one observer who was blinded to the donor–recipient
gender profile performed all of the IVUS measurements.
Quantitative cross-sectional analysis was performed using
commercially available software (TapeMeasure, Indec
Corp., Mountain View, California). Tapes from serial
annual studies were reviewed side-by-side, and appropriate
matching single segments of the proximal LAD were
identified, most of which were immediately proximal to the
first diagonal branch or immediately distal to the bifurcation
of the LMCA. For each cross section, the VA was measured
as the area bound by the external elastic lamina at end
systole. Given that patients with any noticeable intimal
thickening in the target segment were excluded, a three-
layered vessel wall appearance was not the norm, and
intimal area and lumen area were therefore not examined as
separate variables for this study.
Clinical data. Demographic data and immunosuppressant
drug doses were taken from the patients’ transplant, and
medical records and echocardiographic data from medical
and echocardiographic records. Immunosuppressant drug
doses were recorded at the time of the follow-up IVUS
study. End-diastolic dimensions of the interventricular sep-
tum were obtained from reports of echocardiographic ex-
aminations performed within three months of the initial and
follow-up IVUS studies.
Statistical analysis. Data are expressed as the median and
interquartile ranges or mean and standard error or standard
deviation, as appropriate. Differences between groups were
assessed by Kruskal-Wallis one-way analysis of variance on
ranks, with post hoc testing by Dunn’s test (SigmaStat,
Jandel Corp., San Rafael, California). Alternatively, we used
the Mann-Whitney U test when only two groups were
involved. Differences within groups were analyzed using the
Wilcoxon signed-rank test.
RESULTS
Eighty-six pairs of IVUS studies were identified from 86
different patients, spanning either the first (n  41) or
second (n  45) year after heart transplantation. Trans-
plants within the same gender accounted for 48 patients (32
male to male, 16 female to female), and there were 38
cross-gender transplants (17 male to female, 21 female to
male). From these paired studies, 86 disease-free, matched
segments of the proximal LAD were selected for analysis.
Twenty patients were excluded from the study because of
Abbreviations and Acronyms
BSA  body surface area
CABG  coronary artery bypass graft surgery
CAD  coronary artery disease
CsA  cyclosporin A
IVUS  intravascular ultrasound
LAD  left anterior descending coronary artery
LMCA  left main coronary artery
LV  left ventricular
MI  myocardial infarction
VA  vessel area
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intimal thickening or an incomplete IVUS study (6 each
from the female-to-female and female-to-male groups, 5
from the male-to-male group, and 3 from the male-to-
female group).
Clinical characteristics. Clinical and echocardiographic
characteristics are shown in Table 1. Donor age and
recipient age were very similar across the four groups. The
BSA of male donors was greater than that of female donors,
and the initial recipient BSA of male recipients was greater
than that of female recipients. The donor BSA and initial
recipient BSA were well-matched within the four patient
subgroups. The median number of rejection episodes per
patient was similar between the groups, as was the percent-
age requiring increased immunosuppressive drug therapy
(Table 2). Hypertension was uncommon among both do-
nors and recipients at the time of transplantation, although
a substantial percentage of patients received antihyperten-
sive agents during the study period (Table 2).
Changes in VA of proximal LAD with time. At the initial
study, the median VA of the proximal LAD was larger in
male than in female donor hearts, although the difference
was not statistically significant (Table 3). Over the duration
of the study, the VA tended to increase in all patient groups,
although the magnitude of this change differed substantially
between groups. In hearts that were transplanted to a
recipient of the same gender, there were small changes in
VA over time (Table 3, Fig. 1), and, in hearts transplanted
from male donors to female recipients, a small and non-
significant increase in VA was also observed. In contrast, in
female hearts transplanted to male recipients, a striking and
highly significant increase in VA occurred (mean 11.0 
[SEM] 2.4% [SD 14.0%]) (Table 3, Fig. 2). An increase in
VA was seen in 14 of 21 patients studied (7 of 11 and 7 of
10 patients from the first and second post-transplant years,
respectively) and was of a similar magnitude when compar-
ing the first and second post-transplant years (8.1 [SEM]
Table 1. Clinical and Echocardiographic Characteristics
n (First Year/Second Year)















Age (yrs) 25 (15–36) 24 (17–38) 22 (17–29) 23 (18–40) 0.68
Body surface area (m2) 1.66 (1.61–1.72) 1.82 (1.60–1.99) 1.81 (1.58–1.86) 1.97† (1.88–2.08)  0.001
Recipient characteristics
Age (yrs) 52 (49–59) 50 (39–53) 49 (43–55) 53 (42–60) 0.48
Initial
Body surface area 1.66 (1.61–1.72) 1.88‡ (1.76–1.94) 1.77 (1.66–1.85) 2.01§ (1.87–2.05)  0.001
Body weight (kg) 60.2 (59.1–65.3) 75.5‡ (69.0–80.0) 72.0 (62.0–77.3) 82.3§ (73.5–88.5)  0.001
Septal thickness (cm) 1.0 (0.9–1.2) 1.0 (0.9–1.1) 1.0 (1.0–1.2) 1.2‡ (1.1–1.3) 0.007
Follow-up
Body surface area 1.75* (1.61–1.83) 1.91 (1.80–2.03) 1.86* (1.70–1.94) 2.04*§ (1.92–2.14)  0.001
Body weight (kg) 69.0* (59.3–74.8) 79.0* (69.0–80.0) 77.2* (68.0–87.3) 82.5*‡ (75.8–92.8) 0.003
Septal thickness (cm) 1.1 (1.0–1.1) 1.0 (0.9–1.2) 1.1 (0.9–1.2) 1.3*† (1.2–1.4)  0.001
*p  0.05 versus initial value. †p  0.05 versus all other groups. ‡p  0.05 versus female-to-female group. §p  0.05 versus both female recipient groups. Data are presented
as the median value (interquartile range).
Table 2. Immunosuppressant Doses, Rejection Episodes, and Hypertension Data















Cyclosporin A (mg/kg per day) 4.45 (2.85–6.40) 4.30 (3.25–5.16) 3.70 (2.27–4.40) 4.01 (3.23–4.90) 0.35
Prednisone (mg/day) 5.0 (3.5–6.3) 7.5 (2.4–10.0) 5.0 (0–5.6) 10.0* (7.3–11.5)  0.001
Rejection episodes
Total number of episodes 28 24 43 66
Median (range) episodes per patient 0 (0–12) 1.5 (0–4) 2 (0–11) 2 (0–7)
Percentage of episodes requiring
enhanced immunosuppression
57 46 49 44
Hypertension
Donors with hypertension (n) 0 1 0 0
Recipients with hypertension at
baseline (n)
2 4 2 3
Percentage of recipients taking
antihypertensives during study
50 52 59 75
*p  0.05 versus both female recipient groups. Data are presented as the median value (interquartile range), unless otherwise stated.
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4.5% [SD 15.5%] and 11.3  3.9% [SD 14.0%], respec-
tively).
Changes in BSA over time. Body surface area increased
between the initial and follow-up evaluations in all patient
groups—a change that was more pronounced in female
transplant recipients. In the group that had the greatest
LAD enlargement, the female donor–male recipient group,
only a small increase in BSA was observed (Table 1). By
linear regression analysis, we tested whether the change in
VA was dependent on the change in recipient BSA and
found no evidence of a relationship (R2  0.04 , p  0.55).
Changes in interventricular septal thickness with time.
Serial echocardiographic measurements of interventricular
septal thickness were available for 77 of the 86 patients
(Table 1). The initial septal thickness in the male-to-male
group was somewhat greater than that in the other groups
and remained so throughout the follow-up study. There
were no major increases in interventricular septal thickness
between the initial and follow-up studies. In the female
donor–male recipient group, the median initial and
follow-up septal thicknesses were virtually identical.
DISCUSSION
This study shows that in female hearts transplanted into
male recipients, the VA of the proximal LAD increased
significantly over the early transplant years—a change not
seen in hearts transplanted from donors to recipients of the
same gender, nor in male donor hearts transplanted into
female recipients. Concomitant serial echocardiographic
studies showed that this increase in vessel size was not a
response to cardiac hypertrophy, and serial BSA measure-
ments indicated that it was not accounted for by changes in
body size.
Gender, sex hormones, and arterial size. Cardiac surgery
studies have shown that men have larger coronary arteries
than do women (4) and that smaller coronary arterial size is
an independent risk factor for mortality after bypass surgery
(4,11). Furthermore, IVUS showed that the LMCA and
LAD are significantly larger in men, even after correction
for BSA (7) and, hence, that the observed differences
between men and women are not explained simply by
different body size. Although we found that the VA of the
proximal LAD was somewhat larger in men than in women,
this difference did not reach statistical significance. We also
evaluated whether the change in VA during the study was
dependent on the change in BSA over the same time and
found no evidence of a relationship.
The study of sex hormones in relation to vascular biology
has concentrated on the impact of estrogens (and to a lesser
degree, androgens) on arterial reactivity, rather than on
arterial size. In post-menopausal women, intra-arterial in-
fusion of 17-estradiol potentiated endothelium-dependent
vasodilation to acetylcholine in both the forearm (12) and
coronary beds (13), although these effects were not repro-
duced during long-term estrogen administration (14).
The effects of estrogen on vascular reactivity in men
have also been documented. In two studies of transsexuals
taking high-dose estrogen therapy, flow-mediated and
nitroglycerin-mediated brachial artery dilation were en-
hanced when compared with male controls (8,15). It is
interesting that in both studies the baseline brachial artery
diameter was smaller in men taking estrogen than in control
males, consistent with a link between estrogen and arterial
size. This putative link is strengthened by a separate
observation that long-term, high-dose androgen therapy in
transsexual females was associated with a significantly larger
baseline brachial artery diameter than that of control fe-
males (9) and that androgen-deprivation therapy in men
was associated with a slightly smaller baseline brachial
diameter than that of their matched controls (16). Although
these studies were not designed to detect links between sex
hormone status and arterial size, their findings suggest that
androgen or estrogen exposure may have opposing vascular
remodeling effects.
Thus, the distinct remodeling response seen in the
female-to-male group in the present study may be explained
on an endocrine basis. It assumes that these hearts moved
from a high-estrogen, low-androgen environment (healthy
females in their mid-20s) to a high-androgen, low-estrogen
environment (middle-aged men) and that either estrogens
act to reduce coronary arterial size or that androgens
increase coronary arterial size. The fact that coronary
arteries did not get smaller when hearts moved from healthy
males in their 20s (a putative high-androgen, low-estrogen
environment) to women in middle age (a low-androgen
environment) may indicate that estrogens have little direct
impact on coronary size, that most female transplant recip-
ients were postmenopausal (age range 43 to 55 years) and
Table 3. Temporal Changes in VA of the Proximal Left Anterior Descending Coronary Artery
Initial VA (mm2) Follow-Up VA (mm2) p Value
All patients (n  86) 16.37 (15.10–18.53) 17.44 (15.07–19.51) 0.53
Female donors 15.71 (13.81–17.98) 17.03 (14.27–19.21) 0.49
Female recipients (n  16) 15.51 (13.68–18.54) 15.94 (14.08–17.90) 0.63
Male recipients (n  21) 16.13 (13.98–17.98) 17.88 (15.39–19.61) 0.01
Male donors 16.79 (15.38–18.67) 17.66 (15.22–19.68) 0.86
Female recipients (n  17) 16.30 (15.12–17.81) 17.30 (14.56–19.53) 0.55
Male recipients (n  32) 17.08 (15.40–19.54) 17.84 (15.44–19.83) 0.89
Data are presented as the median value (interquartile range).
VA  vessel area.
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therefore did not have high circulating estrogen levels, or
alternatively, that androgen-induced changes in coronary
artery structure are irreversible, irrespective of what endo-
crine environment they subsequently move to.
In the female donor–male recipient group, the magnitude
of vascular enlargement was similar in the first and second
post-transplant years. If these changes are attributed to
endocrine influences, our findings suggest that the effects
are sustained rather than transient. Outward vascular re-
modeling patterns in response to transplant CAD have
previously been shown to be more pronounced when they
occur late than when they occur early post transplantation
(17). Long-term remodeling responses in cross-gender
heart transplants are not addressed in the present study and
may be a focus for future research.
Donor and recipient gender and outcome after heart
transplantation. A variety of studies addressing the ques-
tion of gender and clinical outcomes after heart transplan-
tation have shown that survival is influenced by donor
gender and donor–recipient gender matching but not by
recipient gender. Specifically, reduced long-term survival
rates have been consistently reported in patients who receive
female compared with male donor hearts (18–21) as well as
in gender-mismatched compared with gender-matched
transplants (18,20,21). Among gender-mismatched trans-
plants, the worst survival is seen when female donor hearts
are transplanted to male recipients (18,20,21)—an observa-
tion not readily explained by differences in the number of
rejection episodes (18,20). The present study was not
designed to study clinical outcomes in different heart trans-
plant populations, but it is interesting that we observed
considerable early outward remodeling in a subgroup that
consistently has a worse long-term prognosis than all others.
It may be speculated that outward coronary arterial remod-
eling is not invariably a beneficial or compensatory phenom-
enon and that, in particular circumstances, it is an early
marker of vascular injury or endothelial dysfunction (22).
We excluded patients with evidence of intimal thickening
Figure 1. Percent change in vessel area over time of the proximal segment of the left anterior descending artery in hearts transplanted within the same
gender (female to female  open circles; male to male  open squares) and in hearts transplanted across gender (male to female  solid circles; female
to male solid squares). *p 0.05 compared with baseline. †p 0.05 compared with percent change in vessel area in all other groups. Data are presented
as the mean value  SEM.
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on IVUS at either the initial or follow-up study; hence, we
were unable to detect whether the pattern of arterial
enlargement observed translated to any difference in the rate
of development or progression of transplant CAD.
Influences on vascular remodeling patterns. Arterial re-
modeling occurs in response to diverse physiologic or
pathophysiologic stimuli (23). The former includes growth,
exercise, and increased metabolic demand, whereas the most
common known pathologic stimulus is coronary atheroscle-
rosis. Although gender differences seen in the present study
may intuitively suggest a hormonal influence, other factors
need to be considered.
All of the recipient patients studied were adults with a
minimum age of 39 years (Table 1). It is therefore unlikely
Figure 2. Serial intravascular ultrasound images of the same segment of the proximal left anterior descending artery immediately distal to the bifurcation
of the left main coronary artery in a heart transplanted from a female donor to a male recipient. In the first month after heart transplantation (A), the
cross-sectional area of the left anterior descending artery measured 19.60 mm2, whereas at the first annual transplant evaluation it measured 22.64 mm2,
an increase of 15.5% over one year.
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that the transplanted hearts were exposed to either physio-
logic growth stimuli or excessive exercise training stimuli.
Body surface area is one of several variables considered when
transplant donors are matched to potential recipients, al-
though some variation is frequent. In the present study, the
female donor–male recipient group had a greater donor–
recipient mismatch in median BSA than the other patient
groups (Table 1). However, the magnitude of the difference
was small, and the change in recipient BSA between the
first and second IVUS studies in this group was less than
that found in some other patient groups. The possibility
that donor–recipient BSA mismatch accounted for the
increase in coronary artery size observed is not excluded by
the present study.
Compensatory remodeling in response to transplant
CAD is unlikely to account for the changes we observed.
Although a range of remodeling responses—from overcom-
pensation to no compensation or shrinkage—has been
described in response to transplant CAD (24), an integral
feature of the present study was the exclusion of all vessel
segments that had IVUS evidence of intimal thickening
either at baseline or follow-up. Intravascular ultrasound is a
highly sensitive technique for such intimal thickening and
has become the accepted standard for detection of trans-
plant CAD in vivo. Therefore, it is unlikely that undetected
transplant CAD accounted for the vascular remodeling seen
in these patients.
Immunosuppressant drugs and sex hormone levels. Of
the immunosuppressant agents taken by heart transplant
recipients, both cyclosporin A (CsA) and prednisone may
modulate plasma sex hormone levels. Cyclosporin A causes
dose-dependent hirsutism, but in men and women taking
CsA for rheumatoid arthritis (25) or after renal transplan-
tation (26), circulating testosterone levels were not changed,
and the androgenic effect of CsA was better explained by
accelerated peripheral testosterone metabolism (25). How-
ever, in post-menopausal women with primary biliary cir-
rhosis, plasma estradiol levels were significantly suppressed
by treatment with CsA (27). Oral prednisone therapy is also
associated with suppression of estrogen levels in women (28)
and with suppression of androgen levels in men (29,30).
In the heart transplant population, iatrogenic suppression
of sex hormones is well recognized and is thought to
contribute to accelerated bone turnover in the early post-
transplant years (31). Whether such hypogonadism contrib-
utes to changes in vascular structure is not known, although
the similar drug doses across the four groups of patients,
coupled with disparate remodeling behavior in one patient
group compared with all others, suggest that a ubiquitous
influence like immunosuppressant therapy is unlikely to
adequately explain the present observations.
Study limitations. A predictable limitation of a study of
this size is its potential lack of power to detect subtle
differences between study groups or within groups over
time. This is because of the highly select nature of the study
population: cross-gender heart transplants comprise only a
small percentage of the total transplant population, and
from that small cohort, only a minority have sequential
IVUS data from the early post-operative years. On the other
hand, these constraints on study size mean that observed
differences had to be of considerable magnitude to attain
statistical significance and, hence, were likely to be biologically
important when they arose. Secondly, we chose to use inter-
ventricular septal thickness as a surrogate marker of left
ventricular (LV) mass, with specific reference to the territory of
the artery under investigation—the LAD. This is not the same
as formal measurement of LV mass, although septal thickness
is an integral component of LV mass calculation (32).
Plasma concentrations of sex hormone levels were not
assayed. Thus, although it may be assumed that a group of
young female donors (median age 24 years [range 17 to 38])
is likely to exhibit, on average, a pre-menopausal estrogen
profile, this is not proven conclusively by the present study.
Similarly, it is assumed but not proven that male recipients
exhibited physiologic androgen levels. To confidently as-
cribe the observations made to an endocrine cause, it would
be necessary to demonstrate expected hormone profiles in
the population under investigation.
Finally, post-transplant coronary arteries are a unique
group of vessels for the study of arterial remodeling, in that
they are denervated, have undergone an ischemic insult, and
are exposed to complex immunologic and pharmacologic
stimuli. Although we have taken measures to exclude
confounding as the principal mechanism underlying our
observations, we recognize that they may not translate
completely to the much larger non-transplant population.
Conclusions. In this serial IVUS study, the proximal LAD
of female hearts transplanted into male recipients under-
went significant enlargement early after transplantation, an
effect not seen in any other patient group. The findings were
not explained by confounding due to increased BSA nor by
LV hypertrophy and support a link between host gender and
coronary arterial size, possibly mediated by sex hormone
exposure.
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